rs200706696

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP3BP4_StrongBP6BS2

The NM_020919.4(ALS2):​c.3206G>A​(p.Gly1069Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000439 in 1,614,148 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00056 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00043 ( 3 hom. )

Consequence

ALS2
NM_020919.4 missense

Scores

8
8
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:2

Conservation

PhyloP100: 7.50

Publications

6 publications found
Variant links:
Genes affected
ALS2 (HGNC:443): (alsin Rho guanine nucleotide exchange factor ALS2) The protein encoded by this gene contains an ATS1/RCC1-like domain, a RhoGEF domain, and a vacuolar protein sorting 9 (VPS9) domain, all of which are guanine-nucleotide exchange factors that activate members of the Ras superfamily of GTPases. The protein functions as a guanine nucleotide exchange factor for the small GTPase RAB5. The protein localizes with RAB5 on early endosomal compartments, and functions as a modulator for endosomal dynamics. Mutations in this gene result in several forms of juvenile lateral sclerosis and infantile-onset ascending spastic paralysis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
ALS2 Gene-Disease associations (from GenCC):
  • ALS2-related motor neuron disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • amyotrophic lateral sclerosis type 2, juvenile
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • infantile-onset ascending hereditary spastic paralysis
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • juvenile primary lateral sclerosis
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • juvenile amyotrophic lateral sclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 7: BayesDel_noAF, Cadd, Eigen, MutationAssessor, PROVEAN, REVEL, REVEL [when AlphaMissense, max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.033438057).
BP6
Variant 2-201726526-C-T is Benign according to our data. Variant chr2-201726526-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 333592.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020919.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALS2
NM_020919.4
MANE Select
c.3206G>Ap.Gly1069Glu
missense
Exon 19 of 34NP_065970.2
ALS2
NM_001410975.1
c.3206G>Ap.Gly1069Glu
missense
Exon 19 of 34NP_001397904.1A0A7P0T8F3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALS2
ENST00000264276.11
TSL:1 MANE Select
c.3206G>Ap.Gly1069Glu
missense
Exon 19 of 34ENSP00000264276.6Q96Q42-1
ALS2
ENST00000482891.6
TSL:1
n.3974G>A
non_coding_transcript_exon
Exon 18 of 22
ALS2
ENST00000680497.1
c.3308G>Ap.Gly1103Glu
missense
Exon 19 of 34ENSP00000505954.1A0A7P0Z4F3

Frequencies

GnomAD3 genomes
AF:
0.000565
AC:
86
AN:
152200
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.0127
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000221
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000682
AC:
170
AN:
249412
AF XY:
0.000673
show subpopulations
Gnomad AFR exome
AF:
0.000581
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.0117
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000239
Gnomad OTH exome
AF:
0.00132
GnomAD4 exome
AF:
0.000425
AC:
622
AN:
1461830
Hom.:
3
Cov.:
32
AF XY:
0.000437
AC XY:
318
AN XY:
727222
show subpopulations
African (AFR)
AF:
0.000418
AC:
14
AN:
33476
American (AMR)
AF:
0.000268
AC:
12
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0128
AC:
335
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53408
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.000177
AC:
197
AN:
1111970
Other (OTH)
AF:
0.000960
AC:
58
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
36
72
108
144
180
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000565
AC:
86
AN:
152318
Hom.:
0
Cov.:
32
AF XY:
0.000483
AC XY:
36
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.000481
AC:
20
AN:
41572
American (AMR)
AF:
0.000131
AC:
2
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0127
AC:
44
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000221
AC:
15
AN:
68018
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000810
Hom.:
1
Bravo
AF:
0.000646
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.000269
AC:
1
ESP6500EA
AF:
0.000734
AC:
6
ExAC
AF:
0.000513
AC:
62
EpiCase
AF:
0.000327
EpiControl
AF:
0.000415

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
ALS2-related disorder (1)
-
1
-
Amyotrophic lateral sclerosis (1)
-
1
-
Amyotrophic lateral sclerosis type 2, juvenile (1)
-
1
-
Hereditary spastic paraplegia (1)
-
-
1
Infantile-onset ascending hereditary spastic paralysis (1)
-
1
-
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.33
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Pathogenic
0.34
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.75
D
Eigen
Pathogenic
0.92
Eigen_PC
Pathogenic
0.90
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.98
D
M_CAP
Uncertain
0.23
D
MetaRNN
Benign
0.033
T
MetaSVM
Uncertain
0.51
D
MutationAssessor
Pathogenic
2.9
M
PhyloP100
7.5
PrimateAI
Uncertain
0.69
T
PROVEAN
Pathogenic
-6.6
D
REVEL
Pathogenic
0.84
Sift
Uncertain
0.0030
D
Sift4G
Uncertain
0.0040
D
Polyphen
1.0
D
Vest4
0.70
MVP
0.91
MPC
0.96
ClinPred
0.099
T
GERP RS
5.7
Varity_R
0.86
gMVP
0.88
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200706696; hg19: chr2-202591249; COSMIC: COSV51887150; COSMIC: COSV51887150; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.